cholinesterase inhibitors

Preferred Label : cholinesterase inhibitors;

MeSH definition : Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.;

MeSH synonym : anticholinesterases; drugs, anticholinesterase; anticholinesterase agents; anticholinesterase drugs; anti cholinesterases; inhibitors, cholinesterase; agents, anticholinesterase; anti-cholinesterases; Anticholinesterase Agent; Agent, Anticholinesterase; Anticholinesterase Drug; Drug, Anticholinesterase; Anticholinesterase; Anti-Cholinesterase; Anti Cholinesterase; Cholinesterase Inhibitor; Inhibitor, Cholinesterase;

MeSH hyponym : acetylcholinesterase inhibitors; cholinesterase inhibitors, irreversible; cholinesterase inhibitors, reversible; Inhibitors, Irreversible Cholinesterase; Irreversible Cholinesterase Inhibitors; Inhibitors, Reversible Cholinesterase; Reversible Cholinesterase Inhibitors; Inhibitors, Acetylcholinesterase; Acetylcholinesterase Inhibitor; Inhibitor, Acetylcholinesterase;

MeSH annotation : DF: CHOLINESTERASE INHIB;

Wikipedia link : https://en.wikipedia.org/wiki/Cholinesterase inhibitors;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D002800;

UMLS CUI

C0008425;

ATC code(s)
- physostigmine [ATC Code]
ATC code(s)
- anticholinesterases [ATC Code]
- anticholinesterases [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Acetylcholinesterase Inhibitor [NCIt concept]
- Anticholinesterase [ICD-11 Extension code]
- Anticholinesterase [ICHI extension code]
- Anticholinesterase agents [Bloc CIM-11]
- Product containing cholinesterase inhibitor (product) [SNOMED CT concept]
- Substance with cholinesterase inhibitor mechanism of action (substance) [SNOMED CT concept]
- anticholinesterase drug, nos [SNOMED Notion]
- anticholinesterases [ATC Code]
- anticholinesterases [ATC Code]
False automatic mappings
- Anticholinesterase agents [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of anticholinesterase agents [ICD-10 Sub-category]
Indexing information
- 1,10-bis(pyridinium)decane [MeSH Supplementary Concept]
- 1,2,3,4-tetrahydro-N-(3-iodophenyl-methyl)-9-acridinamine [MeSH Supplementary Concept]
- 1,2,3,4-tetrahydro-N-(phenyl-methyl)-9-acridinamine [MeSH Supplementary Concept]
- 1,8-bis(4-tert-butylpyridinium)oct-1,8-diyl [MeSH Supplementary Concept]
- 1,8-bis(isoquinolinium)-oct-1,8-diyl [MeSH Supplementary Concept]
- 1-(4-(benzo(d)(1,3)dioxol-5-ylmethyl)piperazin-1-yl)-5-(1,2-dithiolan-3-yl)pentan-1-one [MeSH Supplementary Concept]
- 1-(5-(4-((2-acetylphenyl)carbamoyl)phenoxy)pentyl)quinolin-1-ium [MeSH Supplementary Concept]
- 1-methyl-3a-(3-methylbut-2-enyl)-1,2,3,3a,8,8a-hexahydropyrrolo(2,3-b)indole [MeSH Supplementary Concept]
- 2,3-dimethoxy-1,4,5-trihydroxy-10-methylacridone [MeSH Supplementary Concept]
- 2-amino-6-((3-(1-benzylpiperidin-4-yl)propyl)amino)pyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- 3'-hydroxyvoacamine [MeSH Supplementary Concept]
- 3-(anthracen-10-yl)-5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazole [MeSH Supplementary Concept]
- 3-coumaranone [MeSH Supplementary Concept]
- 3-methoxy-1,4,5-trihydroxy-10-methylacridone [MeSH Supplementary Concept]
- 4-(13-amino-10,11,12,14-tetrahydro-9H-benzo(5,6)chromeno(2,3-b)quinolin-14-yl)phenol [MeSH Supplementary Concept]
- 4-(3-ethylthiophenyl)-2-(3-thienyl)-1H-imidazole [MeSH Supplementary Concept]
- 4-(4-ethyl-piperazin-1-yl)-1-(2,3,4-trihydroxyphenyl)butan-1-one [MeSH Supplementary Concept]
- 4-acetoxyplakinamine B [MeSH Supplementary Concept]
- 4-methyl-N-(4-(8,9,10,11-tetrahydro-6H-azocino(2,1-b)quinazolin-13(7H)-ylideneamino)butyl)-N-(3-(8,9,10,11-tetrahydro-6H-azocino(2,1-b)quinazolin-13(7H)-ylideneamino)propyl)pentanamide [MeSH Supplementary Concept]
- 6-hydroxy-4-oxo-N-(10-((1,2,3,4-tetrahydroacridin-9-yl)amino)decyl)-4H-chromene-2-carboxamide [MeSH Supplementary Concept]
- 6-hydroxycrinamine [MeSH Supplementary Concept]
- 7-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one [MeSH Supplementary Concept]
- N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine [MeSH Supplementary Concept]
- N-benzoylphenylalaninyl-N-benzoylphenylalaninate [MeSH Supplementary Concept]
- N1-p-fluorobenzylcymserine [MeSH Supplementary Concept]
- asiatoate A [MeSH Supplementary Concept]
- asiatoate B [MeSH Supplementary Concept]
- atramine [MeSH Supplementary Concept]
- bis(3)-cognitin [MeSH Supplementary Concept]
- bis(9)-normeptazinol [MeSH Supplementary Concept]
- dimethyl-carbamic acid 2,3-bis-dimethylcarbamoyloxy-6-(4-ethylpiperazine-1-carbonyl)phenyl ester [MeSH Supplementary Concept]
- ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo(b)(1,8)naphthyridine-3-carboxylate [MeSH Supplementary Concept]
- furanokurzin [MeSH Supplementary Concept]
- geranylphenazinediol [MeSH Supplementary Concept]
- hopeachinol C [MeSH Supplementary Concept]
- hopeachinol D [MeSH Supplementary Concept]
- luteolin 3',7-di-O-glucoside [MeSH Supplementary Concept]
- luteolin 7-O-(6''-O-acetylglucoside) [MeSH Supplementary Concept]
- lycobscurine A [MeSH Supplementary Concept]
- lycobscurine B [MeSH Supplementary Concept]
- lycobscurine C [MeSH Supplementary Concept]
- macakurzi A [MeSH Supplementary Concept]
- macakurzi B [MeSH Supplementary Concept]
- macakurzi C [MeSH Supplementary Concept]
- mesuagenin B [MeSH Supplementary Concept]
- narciprimine [MeSH Supplementary Concept]
- norfriedelin A [MeSH Supplementary Concept]
- norfriedelin B [MeSH Supplementary Concept]
- norfriedelin C [MeSH Supplementary Concept]
- phenethylcymserine [MeSH Supplementary Concept]
- stenocepflavone [MeSH Supplementary Concept]
- trigolutesin A [MeSH Supplementary Concept]
- zingipain, zingiber officinale [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- acetylcholinesterase [MeSH Descriptor]
- butyrylcholinesterase [MeSH Descriptor]
- cholinesterases [MeSH Descriptor]
Record concept(s)
- acetylcholinesterase inhibitors [MeSH concept]
- cholinesterase inhibitors [MeSH concept]
- cholinesterase inhibitors, irreversible [MeSH concept]
- cholinesterase inhibitors, reversible [MeSH concept]
See also
- insecticides [MeSH Descriptor]
- miotics [MeSH Descriptor]
- organophosphorus compounds [MeSH Descriptor]
- parasympathomimetics [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (9-amino-5,6,7,8-tetrahydroacridin-4-yl)methanol [MeSH Supplementary Concept]
- 1,10-phenanthroline [MeSH Supplementary Concept]
- 14-norhuperzine A [MeSH Supplementary Concept]
- 2,5-hexanedione [MeSH Supplementary Concept]
- 2-chloro-12-(2-piperidinoethyl)dibenzo(d,g)-1,3,6-dioxazocine [MeSH Supplementary Concept]
- 3-hydroxy-2-oxoindole [MeSH Supplementary Concept]
- 3-methyl-2-(4-methyl-1-piperazinyl)-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)quinoline-4-carboxamide [MeSH Supplementary Concept]
- 6,10,14-trimethylpentadeca-5,10-dien-2,12-dione [MeSH Supplementary Concept]
- 6-(ethyl-(2-methoxybenzyl)amino)-1-(1'-(6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)-(4,4')bipiperidinyl-1-yl)hexan-1-one [MeSH Supplementary Concept]
- AP 2238 [MeSH Supplementary Concept]
- Donepezil [MeSH Descriptor]
- N,N'-(3-methyl)phenylenediaminophosphorylchloridate [MeSH Supplementary Concept]
- N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine [MeSH Supplementary Concept]
- N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-N'-(4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl)acetamide [MeSH Supplementary Concept]
- O,O'-(3-methyl)phenylenediphorylchloride [MeSH Supplementary Concept]
- Phenserine [MeSH Supplementary Concept]
- Rivastigmine [MeSH Descriptor]
- TZ2PA6 compound [MeSH Supplementary Concept]
- Z 338 [MeSH Supplementary Concept]
- aldicarb [MeSH Descriptor]
- alternariol [MeSH Supplementary Concept]
- ambenonium chloride [MeSH Descriptor]
- armin [MeSH Descriptor]
- azinphosmethyl [MeSH Descriptor]
- bis(18)-huperzine B [MeSH Supplementary Concept]
- carbaryl [MeSH Descriptor]
- carbofuran [MeSH Descriptor]
- chlorfenvinphos [MeSH Descriptor]
- chlorpyrifos [MeSH Descriptor]
- coumaphos [MeSH Descriptor]
- demecarium [MeSH Supplementary Concept]
- diazinon [MeSH Descriptor]
- dichlorvos [MeSH Descriptor]
- dimethoate [MeSH Descriptor]
- distigmine [MeSH Supplementary Concept]
- echothiophate iodide [MeSH Descriptor]
- edrophonium [MeSH Descriptor]
- ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate [MeSH Supplementary Concept]
- fasciculin [MeSH Supplementary Concept]
- fenitrothion [MeSH Descriptor]
- fenthion [MeSH Descriptor]
- fonofos [MeSH Descriptor]
- galantamine [MeSH Descriptor]
- huperzine A [MeSH Supplementary Concept]
- isoflurophate [MeSH Descriptor]
- isosarcodine [MeSH Supplementary Concept]
- malathion [MeSH Descriptor]
- methanesulfonyl fluoride [MeSH Supplementary Concept]
- methomyl [MeSH Descriptor]
- methyl parathion [MeSH Descriptor]
- mevinphos [MeSH Descriptor]
- monocrotophos [MeSH Descriptor]
- naled [MeSH Descriptor]
- neostigmine [MeSH Descriptor]
- normeperidine [MeSH Supplementary Concept]
- octamethyl pyrophosphoramide [MeSH Supplementary Concept]
- paraoxon [MeSH Descriptor]
- parathion [MeSH Descriptor]
- phenylphosphonothioic acid, 2-ethyl 2-(4-nitrophenyl) ester [MeSH Descriptor]
- phorate [MeSH Descriptor]
- phosalone [MeSH Supplementary Concept]
- phosphamidon [MeSH Descriptor]
- phoxim [MeSH Supplementary Concept]
- physostigmine [MeSH Descriptor]
- physostigmine heptyl [MeSH Supplementary Concept]
- propoxur [MeSH Descriptor]
- pyridostigmine bromide [MeSH Descriptor]
- sarin [MeSH Descriptor]
- soman [MeSH Descriptor]
- tabun [MeSH Supplementary Concept]
- tacrine [MeSH Descriptor]
- tetrachlorvinphos [MeSH Descriptor]
- tetraisopropylpyrophosphamide [MeSH Descriptor]
- trichlorfon [MeSH Descriptor]
- velnacrine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing cholinesterase inhibitor (product) [SNOMED CT concept]
- Substance with cholinesterase inhibitor mechanism of action (substance) [SNOMED CT concept]
- anticholinesterase drug, nos [SNOMED Notion]
- anticholinesterases [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients